Holon, Israel

Abraham Fisher

This inventor holds 26 USPTO granted patents and 2 published patent applications and 2 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Israel Institute for Biological Research, The Purdue Frederick Company, Nsc Therapeutics Gmbh. Active years: 1978-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abraham Fisher. Retrieved from https://idiyas.com/inventor/abraham-fisher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 80.8

 

Average Co-Inventor Count = 2.8

ph-index = 10

Forward Citations = 389(Granted Patents)


Location History:

  • Haifa, IL (2008)
  • Holon, IL (1978 - 2024)

Company Filing History:


Years Active: 1978-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Microglia-Mediated Disorders
Muscarinic Agonist
Bicyclic Heterocycles
Cholinergic System
Spiro Compounds
Central Nervous System
Drug Delivery
Pharmaceutical Composition
Optical Isomers
Quinuclidine Derivatives
Nervous System Disorders
Oxathiolanes
26 patents (USPTO):Explore Patents

Title: The Innovative Work of Abraham Fisher in Holon, IL

Introduction:

Abraham Fisher, a prolific inventor based in Holon, IL, has made significant contributions to the field of pharmaceuticals through his numerous patented inventions. With a total of 25 patents to his name, Fisher stands out as a trailblazer in the industry.

Latest Patents:

His latest patents include the groundbreaking work on "Crystalline polymorphs of a muscarinic acetylcholine receptor agonist." These patents detail novel crystalline forms of a spiro-compound that acts as a muscarinic acetylcholine receptor agonist. The isolated crystalline polymorphs of (S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro[4.5]decane-3-one have shown favorable properties in pharmaceutical manufacture. Fisher's patents also encompass methods for preparing these crystalline polymorphs and converting them into each other, as well as creating medicaments for the treatment of diseases responsive to muscarinic acetylcholine receptor modulation.

Career Highlights:

Throughout his career, Fisher has been associated with esteemed institutions such as the Israel Institute for Biological Research. His exemplary work ethic and dedication to innovation have led to the development of groundbreaking pharmaceutical technologies.

Collaborations:

In his endeavors, Fisher has collaborated with notable individuals in the field, including Nira Bar-Ner and Ishai Karton. These collaborations have further enriched his innovative pursuits and fostered a culture of teamwork and excellence.

Conclusion:

Abraham Fisher's legacy as an inventor in the pharmaceutical industry is characterized by his relentless pursuit of innovation and his commitment to advancing healthcare through groundbreaking technologies. His work continues to inspire and shape the landscape of pharmaceutical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…